PanTher Therapeutics designed its novel controlled release products to deliver chemotherapy locally and potentially eliminate many of the debilitating
side effects which these anti-cancer agents can create when delivered systemically. By changing the route of administration to target just the tumor,
PanTher's devices are designed to increase the amount of drug reaching the intended destination to enhance therapeutic efficacy.
Visit PanTher Therapeutics's website.